Supply Issues Marshall Products Endotracheal Tube FSM7196 (ICN 2859)
Important Customer Notice Status Update Type Supply Disruption
Ref: 2025/2859
ICN Number: 2859
- The supply issue with Endotracheal Tube products from Marshall Products is continuing.
- One product code remains affected in total:
- FSM7196 – Endotracheal Tube Visionary Single Use Standard Cuffed with Murphy Eye 7mm id.
- The affected product code is no longer suspended and is now subject to intermittent supply.
- Potential indirect alternative products are available to order through our online catalogue for the affected products. However, some of these products may also become subject to intermittent supply with the increase in demand.
- See our Downloads ▼ section to access the product listing for further information on the affected product code and potential alternatives.
- The supply issue is now anticipated to be resolved by 12 May 2025.
Change:
- The supplier Marshall Products has informed us of a supply issue with its Endotracheal Tube products.
- One product code is affected:
- FSM7196 – Endotracheal Tube Visionary Single Use Standard Cuffed with Murphy Eye 7mm id.
- The supply issue is due to the supplier experiencing a huge spike in demand for the product.
Impact:
- FSM7196 is currently suspended and unavailable to order.
- Potential indirect alternative products are available to order through our online catalogue.
- The supply issue is anticipated to be resolved by 7 April 2025.
Next Steps:
- Customers are advised to log into our website to view the potential indirect alternative products.
- However, as this is currently a disrupted market and supply is subject to rapid change, the alternatives offered may also be experiencing temporary supply issues and therefore, customers may need to consider clinically reviewing all additional alternatives provided.
- We will update the ICN when we have further information.
- If you have any further questions, please contact your local NHS Supply Chain Customer Services Advisor.
Please note that due to the clinical nature of these alternative products, we advise you to consult your own clinical experts to ensure suitability for your organisations use of these products.